Recent News

11/22/2016
EndoBarrier® Makes Advancement Toward German Reimbursement
Read More

11/08/2016
German Registry Releases Positive EndoBarrier Data at EASD
Read More

10/24/2016
TGA Cancellation of EndoBarrier Listing
Read More


The GI Dynamics’ EndoBarrier® Gastrointestinal Liner System is used for the treatment of obese type 2 diabetes with BMI ≥ 30 kg/m2, or obese patients with BMI ≥ 30 kg/m2 with ≥ 1 comorbidities, or obese patients with BMI >35 kg/m2.
The liner is indicated for maximum implant duration of 12 months.
EndoBarrier is not approved for sale in the U.S. and is limited by federal law to investigational use only in the United States.
CAUTION: INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL (UNITED STATES) LAW TO INVESTIGATIONAL USE